Other Health

LabCorp Prices $400,000,000 in 2.300% Senior Notes Due 2024 and $650,000,000 in 2.950% Senior Notes Due 2029

Monday, November 18, 2019 - 11:45pm

LabCorp (NYSE: LH) announced today that it has priced its offering of $1,050,000,000 in senior notes.

Key Points: 
  • LabCorp (NYSE: LH) announced today that it has priced its offering of $1,050,000,000 in senior notes.
  • The offering consists of two tranches: $400,000,000 aggregate principal amount of 2.300% Senior Notes due 2024 (the 2024 Notes) and $650,000,000 aggregate principal amount of 2.950% Senior Notes due 2029 (the 2029 Notes and, together with the 2024 Notes, the Notes).
  • The Notes will be senior unsecured obligations and will rank equally with LabCorps existing and future senior unsecured debt.
  • Concurrently with this offering, LabCorp is conducting a cash tender offer for up to $300,000,000 aggregate purchase price of its 4.625% Senior Notes due Nov. 15, 2020 (the Tender Offer).

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells

Monday, November 18, 2019 - 6:19pm

Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems.

Key Points: 
  • Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems.
  • The study, entitled Harnessing Type I CRISPR-Cas Systems for Genome Engineering in Human Cells, was published today in the peer-reviewed scientific journal Nature Biotechnology.
  • In the study, Caribou researchers and their collaborators tested whether the multi-protein Class 1 Type I CRISPR-Cas system could be harnessed for human genome engineering.
  • Caribou Biosciences and the Caribou logo are registered trademarks of Caribou Biosciences, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20191118005727/en/

Global Fertility Services Market Report 2019-2024 - Analysis by Cause of Infertility, Procedure, Service, End-user & Region - ResearchAndMarkets.com

Monday, November 18, 2019 - 5:26pm

The "Fertility Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fertility Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
  • The global fertility services market is expected to grow at a CAGR of around 8% during 2019-2024.
  • What is the structure of the global fertility services industry and who are the key players?
  • What is the degree of competition in the global fertility services industry?

Press Ganey Honors Top Performers and Key Industry Contributors at 2019 National Client Conference

Monday, November 18, 2019 - 5:30pm

Press Ganey presented the Physician of the Year Award to Brian Kaminski, MD, Vice President of Quality & Patient Safety at ProMedica Health System.

Key Points: 
  • Press Ganey presented the Physician of the Year Award to Brian Kaminski, MD, Vice President of Quality & Patient Safety at ProMedica Health System.
  • Press Ganey recognized Dr. Kaminski for his passion and commitment to improving the safety and experience of patient care every day.
  • The annual Press Ganey National Client Conference draws more than 3,400 health care executives, physicians, nurses, and other professionals from across the country to learn and collaboratively explore paths toward more patient-centered care.
  • Delivered through a cutting-edge digital platform built on a foundation of data security, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement.

After a Dramatic Rise, the Average U.S. Medical Radiation Doses Now Are Decreasing

Monday, November 18, 2019 - 4:35pm

Except for computed tomography (CT) scans, most medical imaging doses are stable or decreasing.

Key Points: 
  • Except for computed tomography (CT) scans, most medical imaging doses are stable or decreasing.
  • The Report, entitled Medical Radiation Exposure of Patients in the United States, is a 10-year update to an NCRP report published in 2009.
  • The current report updates medical radiation exposure information with data collected between 2006 and 2016.
  • In addition, radiography has moved away from standard film and increased use of digital receptors, leading to lower radiation doses for some procedures.

DIR Fees Pose Serious Challenges for Independent Pharmacies, But the Right PSAO Can Help

Monday, November 18, 2019 - 4:27pm

These confusing payment methodologies compromise the accuracy of the claim reconciliation process and threaten the stability of many independent pharmacies.

Key Points: 
  • These confusing payment methodologies compromise the accuracy of the claim reconciliation process and threaten the stability of many independent pharmacies.
  • The use of DIR fees has increased 45,000 percent since 2010, said Katelyn Lutz, Manager of Pharmacy Programs for Pharmacy First , a pharmacy services administrative organization (PSAO) serving thousands of independent pharmacies across the United States.
  • Lutz explores the answers in How DIR Fees Impact the Independent Pharmacy Industry , a new white paper in which she discusses the evolution and current effects of DIR fees, as well as how the right PSAO can help identify and anticipate their challenges.
  • With a PSAO that is dedicated to their unique issues, Lutz says, independent pharmacy owners can improve their understanding of DIR fees and prepare more thoroughly.

2019 TripleTree iAwards – Call for Applications

Monday, November 18, 2019 - 4:00pm

TripleTree Holdings, LLC, a healthcare merchant that has advised and invested in high-growth healthcare businesses, is pleased to announce a call for applications for the 2019 TripleTree iAwards .

Key Points: 
  • TripleTree Holdings, LLC, a healthcare merchant that has advised and invested in high-growth healthcare businesses, is pleased to announce a call for applications for the 2019 TripleTree iAwards .
  • With the launch of this years iAwards, TripleTree and TT Capital Partners (TTCP) are focused on recognizing earlier stage companies, where there is tremendous innovation occurring across the healthcare industry, said Michael Carroll, chief marketing officer at TripleTree.
  • Companies that provide and offer innovative healthcare technology and services solutions, with annual revenue of $5-25 million, are encouraged to apply for the 2019 TripleTree iAwards.
  • Online applications for the 2019 TripleTree iAwards will be available through December 12, 2019.

Life Image and Graticule Launch GLIMPS in the New AWS Data Exchange

Monday, November 18, 2019 - 3:24pm

Life Image , one of the worlds largest medical evidence networks for clinical and imaging data, and its strategic partner, Graticule , an advanced real world data firm, announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange, a new service that makes it easy for millions of Amazon Web Services (AWS) customers to securely find, subscribe to, and use third-party data in the cloud.

Key Points: 
  • Life Image , one of the worlds largest medical evidence networks for clinical and imaging data, and its strategic partner, Graticule , an advanced real world data firm, announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange, a new service that makes it easy for millions of Amazon Web Services (AWS) customers to securely find, subscribe to, and use third-party data in the cloud.
  • What gets many of our customers excited about AWS Data Exchange is the number of innovative organizations offering novel and unique data on the service, said Stephen Orban, General Manager, AWS Data Exchange, Amazon Web Services, Inc. We are delighted to welcome Life Image and Graticule to the AWS Data Exchange to help the medical community improve patient care.
  • Graticule has published GLIMPS in the AWS Data Exchange.
  • Launching GLIMPS in AWS Data Exchange will allow biopharma and AI companies to accelerate development, post-market safety, effectiveness, validation, and label expansion.

The Medical Alley Association and Accenture Collaborate to Lead the Healthcare Transformation Initiative

Monday, November 18, 2019 - 3:00pm

In a move that reflects Medical Alleys position as the global epicenter of health innovation and care, the Medical Alley Association announces its collaboration with Accenture to lead phase one of the Healthcare Transformation Initiative at Medical Alley (HTIMA), a campaign that will redefine the course of healthcare.

Key Points: 
  • In a move that reflects Medical Alleys position as the global epicenter of health innovation and care, the Medical Alley Association announces its collaboration with Accenture to lead phase one of the Healthcare Transformation Initiative at Medical Alley (HTIMA), a campaign that will redefine the course of healthcare.
  • We look forward to working with the Medical Alley Association to help them further define and lead the evolution of the healthcare industry.
  • HTIMA was founded in 2019 by the Medical Alley Association board of directors and exists to bring healthcares top leaders together for the good of healthcare consumers all over the world, starting in the global epicenter of health innovation and care: Medical Alley.
  • Founded in 1984, the Medical Alley Association supports and advances the global leadership of Medical Alleys healthcare industry and its connectivity around the world.

Evolution Research Group and Invicro LLC Partner to Offer Clinical Research and Advanced Data Analysis and Management Services

Monday, November 18, 2019 - 2:51pm

Today, Evolution Research Group (ERG) and Invicro LLC, a Konica Minolta Company announced a strategic partnership to offer biotech and pharma sponsors early to late phase clinical research trials, advanced data analysis and project management services.

Key Points: 
  • Today, Evolution Research Group (ERG) and Invicro LLC, a Konica Minolta Company announced a strategic partnership to offer biotech and pharma sponsors early to late phase clinical research trials, advanced data analysis and project management services.
  • Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for clinical research.
  • This partnership will offer pharmaceutical sponsors a seamless process for inpatient and outpatient clinical research trials backed by unparallel support including centralized recruiting, operational excellence, clinical consultation, advanced data analysis and project management support.
  • Evolution Research Group, LLC comprises 13 wholly owned and operated clinical research units, and an established network of affiliated clinical research sites.